Phase III Comparison of Tamoxifen Versus Tamoxifen Plus Ovarian Function Suppression in Premenopausal Women With Node-Negative, Hormone Receptor-Positive Breast Cancer (E-3193, INT-0142): A Trial of the Eastern Cooperative Oncology Group

Tevaarwerk Amye J.; Wang Molin; Zhao Fengmin; Fetting John H.; Cella David; Wagner Lynne I.; Martino Silvana; Ingle James N.; Sparano Joseph A.; Solin Lawrence J.; Wood William C.; Robert Nicholas J.

首页> 外文期刊>Journal of Clinical Oncology >Phase III Comparison of Tamoxifen Versus Tamoxifen Plus Ovarian Function Suppression in Premenopausal Women With Node-Negative, Hormone Receptor-Positive Breast Cancer (E-3193, INT-0142): A Trial of the Eastern Cooperative Oncology Group

【24h】

Phase III Comparison of Tamoxifen Versus Tamoxifen Plus Ovarian Function Suppression in Premenopausal Women With Node-Negative, Hormone Receptor-Positive Breast Cancer (E-3193, INT-0142): A Trial of the Eastern Cooperative Oncology Group

机译：三苯氧胺与三苯氧胺加卵巢功能抑制在结节阴性，激素受体阳性乳腺癌的绝经前妇女中的三阶段比较（E-3193，INT-0142）：东方合作肿瘤小组的一项试验

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

Purpose

机译：目的

著录项

来源
《Journal of Clinical Oncology》 |2014年第35期|共11页
作者
Tevaarwerk Amye J.; Wang Molin; Zhao Fengmin; Fetting John H.; Cella David; Wagner Lynne I.; Martino Silvana; Ingle James N.; Sparano Joseph A.; Solin Lawrence J.; Wood William C.; Robert Nicholas J.;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类
关键词

相似文献

外文文献
中文文献
专利

1. Phase III Comparison of Tamoxifen Versus Tamoxifen Plus Ovarian Function Suppression in Premenopausal Women With Node-Negative, Hormone Receptor-Positive Breast Cancer (E-3193, INT-0142): A Trial of the Eastern Cooperative Oncology Group [J] . Tevaarwerk Amye J., Wang Molin, Zhao Fengmin, Journal of Clinical Oncology . 2014,第35期

机译：三苯氧胺与三苯氧胺加卵巢功能抑制在结节阴性，激素受体阳性乳腺癌的绝经前妇女中的三阶段比较（E-3193，INT-0142）：东方合作肿瘤小组的一项试验
2. Adjuvant Tamoxifen Plus Ovarian Function Suppression Versus Tamoxifen Alone in Premenopausal Women With Early Breast Cancer: Patient-Reported Outcomes in the Suppression of Ovarian Function Trial [J] . Ribi Karin, Luo Weixiu, Bernhard Jurg, Journal of Clinical Oncology . 2016,第14期

机译：在早期乳腺癌的绝经前妇女中，辅助用药他莫昔芬加卵巢功能抑制与单独使用他莫昔芬相比：患者报告的抑制卵巢功能试验的结果
3. Twelve-Month Estrogen Levels in Premenopausal Women With Hormone Receptor-Positive Breast Cancer Receiving Adjuvant Triptorelin Plus Exemestane or Tamoxifen in the Suppression of Ovarian Function Trial (SOFT): The SOFT-EST Substudy [J] . Bellet Meritxell, Gray Kathryn P., Francis Prudence A., Journal of Clinical Oncology . 2016,第14期

机译：激素受体阳性乳腺癌的绝经前妇女在抑制卵巢功能试验中接受曲普瑞林加依西美坦或他莫昔芬辅助治疗的十二个月雌激素水平（SOFT）：SOFT-EST子研究
4. Study on the Efficacy Evaluation of Oral Sequential Tamoxifen in Postmenopausal Women with Hormone-dependent Breast Cancer [C] . Na Li, Yahua Sun, Sheng Zhao, International Conference on Life Sciences, Medicine, and Health . 2018

机译：激素依赖性乳腺癌后代妇女口腔序列儿毒素疗效评价研究
5. Phase III Comparison of Tamoxifen Versus Tamoxifen Plus Ovarian Function Suppression in Premenopausal Women With Node-Negative Hormone Receptor–Positive Breast Cancer (E-3193 INT-0142): A Trial of the Eastern Cooperative Oncology Group [O] . Amye J. Tevaarwerk, Molin Wang, Fengmin Zhao, -1

机译：三苯氧胺与三苯氧胺加卵巢功能抑制在结节阴性激素受体阳性乳腺癌的绝经前妇女中的三阶段比较（E-3193INT-0142）：东方合作肿瘤小组的一项试验
6. Phase III Comparison of Tamoxifen Versus Tamoxifen Plus Ovarian Function Suppression in Premenopausal Women With Node-Negative, Hormone Receptor–Positive Breast Cancer (E-3193, INT-0142): A Trial of the Eastern Cooperative Oncology Group [O] . Amye J. Tevaarwerk, Molin Wang, Fengmin Zhao, 2016

机译：III期比较：他莫昔芬与他莫昔芬联合卵巢功能抑制绝经前阴性，激素受体阳性乳腺癌患者（E-3193，INT-0142）：东部肿瘤协作组的试验

Phase III Comparison of Tamoxifen Versus Tamoxifen Plus Ovarian Function Suppression in Premenopausal Women With Node-Negative, Hormone Receptor-Positive Breast Cancer (E-3193, INT-0142): A Trial of the Eastern Cooperative Oncology Group

摘要

著录项

相似文献

相关主题

期刊订阅